精神分裂症神经免疫构建的系统性遗传研究
该研究采用系统性遗传学方法,在精神分裂症患者死后脑组织中通过RNA测序评估免疫基因和通路表达。背外侧前额叶皮质有23个免疫基因差异表达,其中7个在独立数据集中名义显著重复,但效应量极小;海马未见差异表达基因,且无免疫通路差异表达。精神分裂症风险谱评分与免疫通路或差异基因表达不相关,未能证实脑内免疫系统在原发致病中的作用。
要点
- 背外侧前额叶皮质23个免疫基因差异表达,7个在独立数据集重复但效应量极小。
- 海马无免疫基因差异表达,两个脑区均无免疫通路差异表达。
- 精神分裂症风险谱评分与免疫通路或差异基因表达不相关。
核心结论
- 过去关于免疫系统在精神分裂症中具有原发致病作用的报道未能得到证实。
研究设计与样本
- 对精神分裂症患者死后脑组织进行RNA测序,评估561个免疫基因和20条免疫通路在背外侧前额叶皮质(144例精神分裂症和196例对照)和海马(83例精神分裂症和187例对照)的差异表达。
- 在独立死后背外侧前额叶皮质数据集(182例精神分裂症和212例对照)中重复验证差异表达基因。
- 使用来自基因表达矩阵的主成分对RNA质量与诊断的混杂关系进行统计控制。
主要发现
- 背外侧前额叶皮质中23个免疫基因差异表达(错误发现率<0.05)。
- 其中7个基因在独立数据集中方向和名义显著性(P<0.05)均重复,但至少5个基因在非免疫通路中有重要作用,且总体效应量极小(倍数变化<1.1)。
- 海马中未发现单个免疫基因差异表达,两个脑区均无单个免疫通路相对差异表达。
- 基因组精神分裂症风险谱评分与单个免疫通路或差异表达基因的表达不相关。
关键数值与推荐
- 差异表达基因的筛选标准为错误发现率<0.05。
- 重复验证的标准为方向和名义显著性(P<0.05)均一致。
- 效应量以倍数变化<1.1为极小。
临床怎么用
- 临床解读精神分裂症免疫相关研究时需谨慎,脑内免疫系统作为原发致病因素缺乏证据支持。
- 免疫相关生物标志物或治疗靶点的开发应基于更大样本和更严谨的验证。
局限性
- RNA质量与诊断效应高度相关,虽经主成分统计控制但仍可能残留混杂。
- 重复基因的效应量极小,且部分基因在非免疫通路中也有重要作用。
- 研究仅评估特定脑区的免疫基因和通路表达,未涵盖其他脑区或外周免疫指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The role of the immune system in schizophrenia remains controversial despite numerous studies to date. Most studies have profiled expression of select genes or proteins in peripheral blood, but none have focused on the expression of canonical pathways that mediate overall immune response. The current study used a systematic genetic approach to investigate the role of the immune system in a large sample of post-mortem brain of patients with schizophrenia: RNA sequencing was performed to assess the differential expression of 561 immune genes and 20 immune pathways in dorsolateral prefrontal cortex (DLPFC) (144 schizophrenia and 196 control subjects) and hippocampus (83 schizophrenia and 187 control subjects). The effect of RNA quality on gene expression was found to be highly correlated with the effect of diagnosis even after adjustment for observable RNA quality parameters (i.e. RNA integrity), thus this confounding relationship was statistically controlled using principal components derived from the gene expression matrix. In DLPFC, 23 immune genes were found to be differentially expressed (false discovery rate <0.05), of which seven genes replicated in both directionality and at nominal significance (P<0.05) in an independent post-mortem DLPFC data set (182 schizophrenia and 212 control subjects), although notably at least five of these genes have prominent roles in pathways other than immune function and overall the effect sizes were minimal (fold change <1.1). In the hippocampus, no individual immune genes were identified to be differentially expressed, and in both DLPFC and hippocampus none of the individual immune pathways were relatively differentially expressed. Further, genomic schizophrenia risk profiles scores were not correlated with the expression of individual immune pathways or differentially expressed genes. Overall, past reports claiming a primary pathogenic role of the immune system intrinsic to the brain in schizophrenia could not be confirmed.
引用
- Birnbaum R, Jaffe AE, Chen Q, et al. Investigating the neuroimmunogenic architecture of schizophrenia. Mol Psychiatry. 2017. PMID: 28485405. doi:10.1038/mp.2017.89
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。